Sjóvá - Árshlutauppgjör vegna 2. ársfjórðungs 2026 - leiðrétt

Sjóvá-Almennar tryggingar reported Q2 2026 profit of 900 m.kr., supported by underwriting profit of 744 m.kr. (Q2 2025: 690 m.kr.) while investment income was 405 m.kr. vs a Q2 2025 investment loss. For the first six months, profit was 1,138 m.kr. with a combined ratio of 91.2% (vs 91.1% in 6M 2025), and investment asset return improved to 1.0% (from -1.1%). Outlook for 2026 remains unchanged: underwriting profit after tax 1,800–2,500 m.kr. and combined ratio 93–95%, and the company repurchased ~0.3% of shares for 146 m.kr. under a buyback program capped at 500 m.kr.

Analysis

The key signal is that earnings quality improved even though the market backdrop is weak: this is no longer a pure “rates-and-markets” story. For a P&C insurer, sustained sub-95% combined ratios matter more than quarterly investment noise because they imply pricing discipline is still outrunning loss inflation; that tends to support a higher multiple and a more durable capital-return profile than peers whose profits depend on portfolio beta.

The second-order winner is the shareholder, not just the insurer: buybacks plus implied excess capital should compress downside in the stock and make the name relatively defensive versus Icelandic cyclical equities. The risk is that the market may be over-earning on the investment line at exactly the wrong time; if equities weaken or rates back up/down sharply, that line can whipsaw, so the underwrite is really on underwriting margin, not asset returns.

Over the next 1-3 months, the main catalyst is whether management can keep claims benign into 3Q while continuing to return capital. Over 6-18 months, the structural question is whether competitive intensity in Icelandic insurance forces a reversion toward the mid-90s combined ratio; if so, today’s valuation support weakens quickly. The contrarian view is that investors may be underestimating how much of the current strength is coming from a favorable rate regime and one-off capital deployment rather than a step-change in franchise quality.

Key Decisions for Investors

• Tactically accumulate Sjóvá on any post-print weakness; the risk/reward is best if the market fades the investment-income volatility and focuses on underwriting resilience over the next 2-3 quarters.
• Use the company’s buyback as a downside buffer, but do not chase strength after the event; if the stock rerates quickly, trim into the move because the near-term upside is likely capital-return driven rather than estimate revision driven.
• Watch the 3Q combined ratio and investment return closely; a move back above 95% or a material drop in invested-asset returns would falsify the thesis and should trigger de-risking.
• For relative value, prefer a long Sjóvá versus a more market-sensitive Icelandic financial/consumer cyclicals basket if you can source a clean local pair; the insurer is the cleaner defensive cash-flow story.
• No options expression is compelling unless liquidity is deep enough to price an event move; in a small-market name, spot equity exposure is the cleaner trade.